YogenthiranSaunthararajahMD

PubMed

• 14 citations
  Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancer.
  Stephanie Gomez, Olivia L Cox, Reddick R Walker 3rd, Uzma Rentia, Melissa Hadley
  Journal for Immunotherapy of Cancer. 2022-11-01
• 6 citations
  Changing paradigms in oncology: Toward noncytotoxic treatments for advanced gliomas.
  Nikolaus von Knebel Doeberitz, Daniel Paech, Dominik Sturm, Stefan Pusch, Sevin Turcan
  International Journal of Cancer. 2022-11-01
• 4 citations
  Functional characterization of NPM1-TYK2 fusion oncogene.
  Sudhakiranmayi Kuravi, Riley W Baker, Muhammad Umair Mushtaq, Irfan Saadi, Tara L Lin
  NPJ Precision Oncology. 2022-01-18

Abstracts/Posters

• CUL1: Novel Therapeutic Target in Myeloid Neoplasms Harboring -7/Del(7q)
  Yogenthiran Saunthararajah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Single Arm, Phase II Study of Eltrombopag to Enhance Platelet Count Recovery in Older Patients with Acute Myeloid Leukemia (AML) Undergoing Remission Induction Therapy
  Yogenthiran Saunthararajah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Extended Experience with a Very Low Dose, Metronomic, Subcutaneous Decitabine Regimen Intended to Deplete DNMT1 without Cytotoxicity
  Yogenthiran Saunthararajah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Integrated Analysis of Copy-Number Alterations and Gene Mutations in 2,000 Patients with Myeloid Neoplasms
  Yogenthiran Saunthararajah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Large Granular Lymphocytic Leukemia Coexists with Clonal Hematopoiesis of Indeterminate PotentialClinically Relevant Abstract
  Yogenthiran Saunthararajah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Feedback Responses of the Pyrimidine Metabolism Network Mediate Resistance to Decitabine and 5-Azacytidine
  Yogenthiran Saunthararajah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• FA Gene Carrier Status Predisposes to Myeloid Neoplasms and Bone Marrow Failure in AdultsClinically Relevant Abstract
  Yogenthiran Saunthararajah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Iron Catalyzed Hydrogen Sulfide and Its Prevalence during Oxidative Events in Sickle Cell Disease
  Yogenthiran Saunthararajah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Eltrombopag Creates a Transient Chemical Phenocopy of TET2 Loss of Function That Contributes to Hematopoietic Precursor ExpansionClinically Relevant Abstract
  Yogenthiran Saunthararajah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• A First-in-Class Inhibitor of ISWI-Mediated (ATP-Dependent) Transcription Repression Releases Terminal-Differentiation in AML Cells While Sparing Normal Hematopoiesis 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• The LSD1 Inhibitor RN-1 Increases I-Globin . Expression in Baboons By Targeting an Early Event Responsible for I-Globin Repression 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Ultimate Precision: Targeting Cancer but Not Normal Self-Replication 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018